CSBR icon

Champions Oncology
CSBR

Overview Fund Activity

30 hedge funds and large institutions have $50.4M invested in Champions Oncology in 2022 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 2 closing their positions.

Holders
30
Holders Change
-1
Holders Change %
-3.23%
% of All Funds
0.47%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
1
Increased
8
Reduced
8
Closed
2
Calls
$1.83M
Puts
–
Net Calls
+$1.83M
Net Calls Change
+$1.83M

Top Buyers

1
Citadel Advisors
1
Citadel Advisors
Florida
$131K
2
EIM
2
Essex Investment Management
Massachusetts
$936K
3
MAG
3
Millrace Asset Group
Pennsylvania
$2.68M
4
Vanguard Group
4
Vanguard Group
Pennsylvania
$2.81M
5
UBS Group
5
UBS Group
Switzerland
$24K

Top Sellers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$1.38M
2
OMC
2
Overbrook Management Corp
New York
$519K
3
CAM
3
ClariVest Asset Management
California
$392K
4
MTWM
4
Masso Torrence Wealth Management
New Jersey
$0
5
SFI
5
Susquehanna Fundamental Investments
Pennsylvania
$219K
Name Holding Trade Value Shares
Change 		Shares
Change %
Morgan Stanley
26
Morgan Stanley
New York
$55K -$5.88K -728 -10%
UBS Group
27
UBS Group
Switzerland
$24K +$21.8K +2,742 +979%
Royal Bank of Canada
28
Royal Bank of Canada
Ontario, Canada
$1K – – –
MTWM
29
Masso Torrence Wealth Management
New Jersey
– -$8K -1,000 Closed
Bank of America
30
Bank of America
North Carolina
– -$1K -147 Closed
1
2